GoodRx Holdings, Inc. GDRX EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from GoodRx Holdings, Inc.’s reported figures.
Based on trailing twelve months.
The official record: GoodRx Holdings, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about GoodRx Holdings, Inc.'s ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GoodRx Holdings, Inc.'s EBITDA margin?
- GoodRx Holdings, Inc. (GDRX) reported EBITDA margin of 20.8% in Q1 2026.
- How has GoodRx Holdings, Inc.'s EBITDA margin changed year-over-year?
- GoodRx Holdings, Inc.'s EBITDA margin increased by 6.3% year-over-year, from 19.6% to 20.8%.
- What is the long-term trend for GoodRx Holdings, Inc.'s EBITDA margin?
- Over 5 years (2020 to 2025), GoodRx Holdings, Inc.'s EBITDA margin has grown at a -14.2% compound annual growth rate (CAGR), from -46.7% to 21.7%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.